Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare
Esperion Therapeutics Inc. EPS 2018–2025
Esperion Therapeutics Inc. annual/quarterly eps history and growth rate from 2019 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Esperion Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.10, a 52.38% decrease year-over-year.
- Esperion Therapeutics Inc. annual eps for 2025 was $0.11, a 60.71% decrease from 2024.
- Esperion Therapeutics Inc. annual eps for 2024 was $0.28, a 86.21% decrease from 2023.
- Esperion Therapeutics Inc. annual eps for 2023 was $2.03, a 42.33% decrease from 2022.
- Esperion Therapeutics Inc. annual eps for 2022 was $3.52.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Esperion Therapeutics Inc. EPS — FAQ
Esperion Therapeutics Inc. (ESPR) eps over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Esperion Therapeutics Inc.'s eps?
Esperion Therapeutics Inc. (ESPR) reported eps of $-0.11 for fiscal 2025.
Where can I see ESPR's eps history?
The chart and table above show Esperion Therapeutics Inc.'s eps by year and by quarter, including the growth rate.